Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Learn the telltale signs you should revise your budget, including income changes, expense spikes, and shifting priorities.
24,979 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A freshly launched crypto-transfer feature helped push Interactive Brokers stock bumped higher by nearly 4% today. Th...
On a day when the S&P 500 slipped, KLA Corporation stood out. An aggressive price-target upgrade and a scheduled stoc...
This year brought a sharp retreat in Accenture’s stock. The drop isn’t just a price move—it's a signal. This guide br...
Institutional moves can reshape a niche tech stock overnight. This article breaks down the recent liquidation by Loun...
A stock surged 125% in 2026, turning heads across the market. This deep-dive breaks down the drivers of the move, how...
A new survey of 150 enterprise leaders shows procurement friction is slowing AI deals as buyers struggle to map budge...
Warren Buffett’s transition at Berkshire Hathaway ushers in a new era. Yet three longtime favorites—Apple, American E...
Lilly stock has faced pressure, but one key driver could keep it in buy territory. This article unpacks the core reas...
A sharp price drop followed by a sizable insider sale can mean many things. This guide walks through what to watch in...
A new kind of space stock is building recurring AI-powered intelligence from satellites. This article breaks down the...
Congressional leaders broker a bicameral agreement that bans a federal digital currency before 2030 while reviving ho...